Currently browsing tag


VW receives regulatory approval for fixes on 1.1 million cars

Volkswagen said on Wednesday it received regulatory approval to fix another 1.1 million cars, raising the number of VW models cleared for refitting to more than 2.5 million since the start of the year. Germany's motor vehicle authority KBA has approved fixes for VW brand models, VW commercial vehicles and Audi luxury cars including the Tiguan SUV and Caddy model with 2.0 liter TDI EA 189 engines, the carmaker said. VW said the KBA has confirmed that the fixes would not result in any changes to fuel consumption, performance or noise emissions of the affected cars.

Trying to stem refugee influx, Sweden asks: When is a child not a child?

By Alistair Scrutton and Sven Nordenstam STOCKHOLM (Reuters) – Under huge strain from an influx of unaccompanied children seeking asylum, the Swedish government faces political pressure to undertake medical tests like X-rays to vet the age of young refugees despite opposition from doctors and lawyers. The controversy reflects tensions over surging immigration into the Nordic country of 10 million after a public backlash that saw controls reimposed on the border with Denmark, from which most migrants have entered Sweden. Sweden took in 163,000 asylum seekers last year, the most per capita in Europe.

Sacked Sanofi boss joins PureTech board

Chris Viehbacher, sacked as chief executive of French drugs firm Sanofi last year, is to join the board of PureTech, a privately owned healthcare science and technology R&D company. Boston-based PureTech's co-founder and senior partner Robert Langer said in a statement he had known the German-Canadian Viehbacher for many years “and I am very excited that we will be working together more closely now”. Viehbacher, who moved to Boston last year while he was still running Sanofi, raised the French company's multinational profile during his six years in the job by completing over $30 billion of acquisitions including that of Boston-based Genzyme.